patient and family approach

KNCV believes in a programmatic and patient/family approach, and in diagnosis and treatment for all. KNCV supports the introduction of new diagnostic tools, TB drugs and regimens and helps to prepare countries and national TB programs for a rapid uptake.

With KNCV’s Right Diagnosis, Right Treatment initiative we aim to accelerate the processes required for adoption, implementation and scale-up of new tools, including policies and approaches, diagnostic and other technologies, and TB drugs – comprehensively and systematically. We do this in the context of the programmatic management of TB for children and adults.

KNCV’s ‘Patient Triage’ approach

At its core is KNCV’s TB Patient Triage Approach. It promotes access to rapid, highly sensitive and specific molecular tests to detect TB and various forms of DR-TB (if present) coupled with new drugs and regimens. It offers early and correct ‘triaging’ of patients to the least toxic, shortest, most appropriate and effective regimen according to individualized rapid patient drug susceptibility test (DST) results.

The concept of right diagnosis right treatment has benefits at all levels

  • Patients

    Early treatment, Lowest side effects, Improved quality of live

  • Health systems

    Less costly treatments, Easier to administer, Better treatment rates

  • Public health

    Reduce risk transmissions, Reduce DR-TB, Revert the TB burden

Vision and mission

Vision
A world free of tuberculosis

Mission
Right diagnosis and right treatment for every TB patient

How KNCV helps

By now KNCV has helped with the successful implementation of new drugs and shorter treatment regimen in 21 countries.

  • 22/08/2018

    KNCV applauds new guidance on MDR-TB treatment

    KNCV welcomes the new guidance issued by WHO on the treatment of drug resistant TB and applauds this important step…

    Lees meer
  • 25/07/2018

    Bedaquiline price reduction could benefit patients worldwide

    During a pre-conference event of the International AIDS Conference in Amsterdam this year, the Minister of Health of South Africa,…

    Lees meer
  • 27/06/2017

    Baby Steps and Big Victories: Fighting Drug-Resistant TB in Kyrgyzstan

    By Tristan Bayly and Bakyt Myrzaliev. The USAID-funded Challenge TB project is supporting the introduction of shorter regimens and new…

    Lees meer
  • 23/02/2017

    Behind the Scenes at MDR-TB Enrollment in Kyrgyzstan and Tajikistan

    Since the end of last year, KNCV and partners have been enrolling patients with multi-drug resistant-TB (MDR-TB) in…

    Lees meer

Want to know more? Contact our experts

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.